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Background: In healthy lungs, deposited micrometer-sized particles are efficiently phagocytosed by macrophages
present on airway surfaces; however, uptake of nanoparticles (NP) by macrophages appears less effective and is
largely unstudied in lung disease. Using mouse models of allergic asthma and chronic obstructive pulmonary
disease (COPD), we investigated NP uptake after challenge with common biogenic ambient air microparticles.
Methods: Bronchoalveolar lavage (BAL) cells from diseased mice (allergic asthma: ovalbumin [OVA] sensitized and
COPD: Scnn1b-transgenic [Tg]) and their respective healthy controls were exposed ex vivo first to 3-μm fungal spores of
Calvatia excipuliformis and then to 20-nm gold (Au) NP. Electron microscopic imaging was performed and NP uptake
was assessed by quantitative morphometry.
Results: Macrophages from diseased mice were significantly larger compared to controls in OVA-allergic versus sham
controls and in Scnn1b-Tg versus wild type (WT) mice. The percentage of macrophages containing AuNP tended to
be lower in Scnn1b-Tg than in WT mice. In all animal groups, fungal spores were localized in macrophage phagosomes,
the membrane tightly surrounding the spore, whilst AuNP were found in vesicles largely exceeding NP size,
co-localized in spore phagosomes and occasionally, in the cytoplasm. AuNP in vesicles were located close to the
membrane. In BAL from OVA-allergic mice, 13.9 ± 8.3% of all eosinophils contained AuNP in vesicles exceeding
NP size and close to the membrane.
Conclusions: Overall, AuNP uptake by BAL macrophages occurred mainly by co-uptake together with other material,
including micrometer-sized ambient air particles like fungal spores. The lower percentage of NP containing
macrophages in BAL from Scnn1b-Tg mice points to a change in the macrophage population from a highly to
a less phagocytic phenotype. This likely contributes to inefficient macrophage clearance of NP in lung disease.
Finally, the AuNP containing eosinophils in OVA-allergic mice show that other inflammatory cells present on airway
surfaces may substantially contribute to NP uptake.
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Epidemiologists have consistently found an association
between particulate air pollution and adverse health
effects in humans [1,2]. Thereby, a specific toxicological
role was attributed to ultrafine particles (UFP, particles
with aerodynamic diameters ≤ 100 nm), and individuals
with pre-existing respiratory and cardiovascular diseases* Correspondence: marianne.geiser@ana.unibe.ch
1Institute of Anatomy, University of Bern, Bern, Switzerland
Full list of author information is available at the end of the article
© 2014 Geiser et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.were found to be more vulnerable to particle concentration
increase in ambient air. Aerosol therapy in its modern form
is an indispensable tool for topical treatment of pulmonary
diseases and is increasingly used for systemic therapy [3].
The fast development of nanotechnology has brought about
novel delivery strategies for inhaled and target-specific
drugs for therapeutic applications, vaccines and diagnostics
[4,5]. Gold nanoparticles (AuNP) are a candidate material
for therapeutic applications, however little is known about
how AuNP interact with different cell types [6]. Due to thetd. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Geiser et al. BMC Pulmonary Medicine 2014, 14:116 Page 2 of 13
http://www.biomedcentral.com/1471-2466/14/116high deposition efficiency of nanoparticles on the surface of
the entire respiratory tract [7] and the health effects of UFP
reported in humans (e.g. [8]), it is important to understand
the interactions of deposited AuNP with target cells.
Macrophages, which patrol airway surfaces and are
key players in lung defense, are one of the first cells to
come into contact with inhaled and deposited particles.
Surface macrophages function primarily to phagocytose
deposited particles; clearing them from the airway surface
and minimizing their impact on the epithelium and
underlying tissues [9]. Phagocytosis of micrometer-sized
particles is fast and essentially completed within 24 hours
[10]. Uptake of NP by surface macrophages, however,
seems to differ from that of micrometer-sized particles, as
evidenced by inefficient phagocytosis of inhaled 20-nm
titanium dioxide (TiO2) NP in the lungs of healthy rats
[11]. Since particle uptake by macrophages is important
for lung homeostasis, these cells also likely play a role in
lung pathogenesis. Allergic asthma and chronic obstruct-
ive pulmonary disease (COPD) are the two most relevant
inflammatory lung diseases in humans [12,13]. Allergic
asthma is primarily an airway disease with goblet cell
hyperplasia, increased airway reactivity and influx of
eosinophils. The pathophysiology of COPD is caused by
inhaled noxious particles and/or gases that trigger
inflammatory responses in the conducting airways, i.e.
chronic bronchitis, as well as a continuous destruction
of the alveolar airspaces, i.e. emphysema. Symptomatically,
patients suffer from chronic cough and dyspnea resulting
from increased mucus secretion and airflow obstruction;
impaired macrophage clearance of deposited particles
is likely an important factor in the development and
progression of both diseases.
In asthma, impaired macrophage clearance of microm-
eter-sized particles has been reported, e.g. bacteria in
children [14] and 2-μm polystyrene microspheres in
murine experimental asthma [15]. Submicrometer parti-
cles, however, were more rapidly phagocytosed by sputum
macrophages of asthmatics than healthy subjects [16].
In COPD, phagocytic activity of surface macrophages
seems to be decreased independent of particle size; e.g.
reduced uptake of apoptotic cells has been reported [17],
and we recently obtained evidence for delayed and less
efficient uptake of inhaled 20-nm AuNP in Scnn1b-Tg
mice with COPD-like lung disease [18]. Contrary to
the consequences of harmful NP, impaired phagocytosis
resulting in a prolonged residence time of deposited
AuNP on the epithelial surface may be favorable in case of
therapeutic targeting of the lung parenchyma by inhaled
aerosols.
Fungal spores are ubiquitous components of occupational
and residential indoor as well as outdoor air, and they
have long been associated with allergic and non-allergic
respiratory diseases [19-21]. The quantities of airbornefungal spores are generally 100 - 1000 times greater
than those of pollen grains; there are usually 103 - 104
spores/m3 air with peak values of 106 spores/m3 [22].
Contrary to pollen grains, the regional differences in
the outdoor fungal spore occurrence are rather small,
at least in the northern hemisphere. Basidiomycetes
represents the largest and most complex group of fungi,
and their spores regularly constitute the major portion
of the spore-load in ambient air [23,24]. Our respiratory
tract is frequently challenged by inhaled basidiospores, e.g.
from Calvatia species, which are 3 - 5 μm in diameter
and are known to deposit in conducting airways and
alveoli [25,26]. In order to unravel the mechanisms of
beneficial or adverse effects of inhaled nanoparticles,
the role of other, frequently inhaled particles with known
participation in lung disease need to be included in model
studies. Knowledge regarding NP uptake by surface mac-
rophages after a challenge with common air constituents
such as fungal spores is lacking in the literature.
This study aimed to investigate the uptake and local-
ization of AuNP at the ultrastructural, i.e. individual particle
level, in spore-challenged bronchoalveolar (BAL) cells
harvested from murine models of common inflammatory
lung diseases, (i) in OVA-induced experimental allergic
asthma, which is characterized by acute lung inflamma-
tion with increased BAL eosinophils [27], and (ii) in
COPD, represented by Scnn1b-Tg mice, which mimic key
aspects of chronic obstructive lung diseases in humans,
including chronic bronchitis with airway mucus obstruc-
tion, inflammation with increased BAL leukocytes and
structural lung damage [28-30].
Combining exposure to a potential inhalative nanocarrier
with ultrastructural analysis of macrophages in healthy and
diseased lungs, we report here the mode and efficiency
of macrophage AuNP clearance in the presence of ubi-
quitous biogenic ambient air microparticles. We further
demonstrate effects of (i) disease status, (ii) airway surface
leukocyte populations and (iii) mouse strain on macro-
phage AuNP clearance, which are all relevant for their use
in therapeutic applications.
Methods
Experimental models of airway disease
Murine models were used to investigate particle uptake
in conditions representing allergic asthma and COPD
as well as in corresponding healthy controls (Figure 1).
Recovery, treatment and analysis of BAL cells were
identical in all animal groups.
Allergic airway inflammation was induced using an
adjuvant-free experimental asthma protocol as previously
described [27]. Briefly, animals (ten female BALB/c mice
aged 6 - 8 weeks purchased from Harlan Winkelmann,
Borchen, Germany) were sensitized by subcutaneous
injection of 10 μg OVA (grade VI, Sigma, Steinheim,
Figure 1 Illustration visualizing the study design. BAL cells of
two well-described mouse models of lung diseases (OVA-allergic
and Scnn1b-Tg, and their respective controls, i.e. sham-sensitized
and WT mice) were sequentially exposed ex vivo to fungal spores
and AuNP to assess their particle uptake capability by TEM and
morphometric measurements.
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[dose used for sensitization]) in 200 μL phosphate buff-
ered saline (PBS, Sigma, Steinheim, Germany) or sham
injections of PBS on days 0, 7 and 14. Allergic airway
inflammation was induced by 20 minutes of 1% OVA
or sham PBS aerosol exposure on days 26, 27 and 28.
BAL cell isolation was performed 24 h after the last
allergen challenge.
The Scnn1b-Tg mouse is an established model of chronic
inflammatory lung disease exhibiting key features of COPD
and CF such as chronic airway inflammation, mucus
obstruction and structural lung damage [28-32]. Five
Scnn1b-Tg mice (airway targeted overexpression of the
epithelial Na+ channel β subunit Scnn1b; line 6608
generated and maintained on a mixed C3H/HeN:C57BL/
6N genetic background as previously described [30]
and five WT littermates aged 16 - 18 weeks, were bred
and reared at the University of Heidelberg, Heidelberg,
Germany. Mouse progeny were genotyped by tail biopsy
polymerase chain reaction (PCR) as previously described
[33]. Animals were housed under a 12 h light/dark cycle,
controlled humidity of 55% and temperature of 22°C, with
access to food and water ad libitum.
For cell retrieval, animals were deeply anesthetized
by intraperitoneal injection of 300 mg/Kg ketaminehydrochloride plus 30 mg/Kg xylazine (Rompun, Bayer
Health Care, Leverkusen, Germany) prior to exsan-
guination by cutting the abdominal aorta and lung
lavage.
All experiments were performed under federal guidelines
for the use and care of laboratory animals and were approved
by the responsible local authorities (Regierungspräsidium
Giessen, Germany; Regierungspräsidium Karlsruhe, Germany;
and the Cantonal Veterinary Office, Bern, Switzerland)
and included ethical evaluation.
Particles
Basidiospores of the Calvatia species were selected,
since these spores have been well characterized in terms
of their morphology and surface properties as well as
their distribution, retention and clearance by macrophages
in rodent lungs upon inhalation [26,34]. In addition, all
analyses were performed in comparison to other particle
types of the same size [9,34]. Fungal spores of Calvatia
excipuliformis (3.5 μm in diameter), collected from dried
mushrooms as previously described [26], were suspended
at a density of 2 × 107 particles/mL in fluorocarbon FC-72
(3 M, Neuss, Germany).
Similarly, valuable background information on AuNP
for this in-vitro study was retrieved from very recent
inhalation experiments with spark generated 20-nm AuNP
using the same COPD animal model [18]. Colloidal gold
particles (AuNP, 20 nm in diameter), suspended at 1 × 1011
particles/mL in citrate buffer, were obtained from Plano
(Wetzlar, Germany).
BAL cell isolation, cell culture and particle exposure
Lungs were lavaged with 5 × 1 mL sterile PBS as described
previously [11]. Total number of BAL cells was determined
using a Neubauer haemocytometer chamber. Differential
cell counts (200 BAL cells per animal) were performed
either on cytospin preparations (OVA-allergic and sham-
sensitized mice) fixed and stained with Diff-Quick
(Merz & Dade AG, Düdingen, Switzerland) or directly
on filter-insert cell preparations (Scnn1b-Tg and WT
mice) fixed with phosphate buffered 2.5% glutaraldehyde
(EMS, Fort Washington, PA, USA). Macrophages, lympho-
cytes, eosinophils and neutrophils were differentiated by
standard morphologic criteria.
For each animal, 3 × 105 BAL cells in 100 μL complete
medium (Dulbecco’s Modified Eagle’s Medium, D-MEM,
supplemented with 10% fetal calf serum, FCS) were seeded
on a micro-porous filter insert (pore size: 0.4 μm,
growth area: 0.3 cm2, i.e. 1 × 106 cells/cm2; Falcon, Becton
Dickinson, Franklin Lakes, NJ, USA) in 24-well plates
(Falcon), with each well containing 800 μL complete
D-MEM. Cells were then cultured for 2 h at 37°C, 5%
CO2 and 90% RH to select for adherent cells, i.e. macro-
phages and activated leukocytes (eosinophils, neutrophils,
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surface. Non-adherent cells were washed off with serum-
free D-MEM. Thereafter, sequential exposure of cells to
the particles followed. Like this, concurrent exposure of
micro- and nanoparticles was avoided to omit passive
carriage of the smaller (nano)particles on the surface of the
larger (micrometer sized) ones. To challenge phagocytosis,
the remaining cells were first exposed to 1 × 106 fungal
spores (~ 3 spores/cell) in 100 μL serum-free D-MEM/
insert for 2 h. Subsequently, non-adherent spores were
washed off with 300 μL serum-free D-MEM/insert and
BAL cells were then exposed to 1 × 109 AuNP (~ 3 ×
103 NP/cell) in 100 μL serum-free D-MEM (zeta
potential ~ 22 mV [35]) for 4 h. Non-adherent AuNP
were rigorously washed off with 2 × 300 μL serum-free
D-MEM/insert and 1 × 500 μL PBS. BAL cells were then
successively fixed with 500 μL of 2.5% glutaraldehyde
(EMS) in 0.03 M potassium-phosphate buffer, 1% osmium
tetroxide in 0.1 M sodium-cacodylate buffer and 0.5%
uranyl acetate in 0.05 M maleate buffer (Sigma-Aldrich,
Buchs, Switzerland), dehydrated in a graded series of
ethanol and embedded in epon resin (Sigma-Aldrich).
Ultrathin sections of 50 nm nominal thickness were cut
perpendicular to the filter-insert with an ultra-microtome
(Ultratome, LKB, Stockholm, Sweden), mounted onto
formvar-coated 200-mesh copper grids and post-stained
with uranyl acetate and lead citrate (Ultrastain, Leica,
Glattbrugg, Switzerland). For electron tomography, 150-
nm sections were cut, mounted and stained as described
above.
Microscopic analysis of cells and particles
BAL cell morphology was first evaluated on toluidine
blue stained sections of 1 - 2 μm nominal thickness using
a Leica light microscope (Leica, Wetzlar, Germany). Ultra-
structural analysis of cells and particles was performed on
random ultrathin sections of the cells on filter inserts
using a CM12 transmission electron microscope (TEM,
Phillips, Eindhoven, The Netherlands) operated at 80 kV.
For each animal model, approximately 150 cells were
analyzed by TEM. Fungal spores and AuNP were
unambiguously identified according to their size, shape
and contrast. The diameters of macrophages, vesicles and
particles are reported, since this is the common measure
in cell biology. Equivalent diameters were calculated from
section profile area measurements of the cell, vesicle or
particle using the iTEM software (Olympus Soft Imaging
Solutions, Münster, Germany).
For electron tomography, the 3D configuration of AuNP
and surrounding structures was acquired by projection
reconstruction of a multi-angular tilt series of thick
sections (~ 150 nm) [36]. Electron tomography was per-
formed on five vesicles containing AuNP using a Tecnai
F20 field emission TEM (FEI Company, Eindhoven,Netherlands) operating at 200 kV. Typical tilt series
were acquired at a magnification of 40,000× covering
an angular range from -66° to 66° (with an increment of
2°) and a defocus of 0.53 μm. The pixel size in the
tomogram was 0.51 nm. Tilt images were aligned semi-
manually using the FEI software package (Inspect 3D,
Amira, FEI Company, Eindhoven Netherlands). Three
dimensional reconstructions of AuNP and segmentation
of macrophage vesicles in the tomogram were performed
manually with the segmentation editor implemented in
Amira software.Statistics
BAL cells from all animal groups were treated the same
way, i.e. first with spores and then with AuNP. Thus
particle treatment was a within-subject (single measure)
factor, while animal model (mouse strain) as well as allergy
and COPD status was a between-animal factor. Due to the
applied sampling design of analyzing all AuNP-containing
vesicles in a macrophage, the number of data points
obtained varied between macrophages and animals. Data
of BAL cell number, macrophage size and distance of
particles to vesicle membrane were analyzed by the
non-parametric Mann-Whitney Rank Sum Test for two
group comparisons and one-way analysis of variance
(ANOVA) followed by Dunn or Holm-Sidak post hoc
tests for pairwise multiple group comparisons. These
analyses were performed using SigmaPlot 12 software
(Systat Software Inc., San Jose, CA, USA). Data of vesicle
to particle size ratios, RV/P were analyzed for differences in
the mechanism of AuNP uptake. A linear mixed effects
model with a random intercept for each animal and fixed
effects for health status, disease model/mouse strain and
their interaction health status*disease model and vesicle
class was used to model the logarithm of RV/P (log[RV/P]),
where the log transformation was chosen for linearization
and diagnostic reasons. These analyses were performed
with R software version R-2.13.0. A P-value < 0.05 was
considered to be statistically significant. Descriptive statis-
tics such as number of observations, mean, standard error
of the mean (SEM) and range (minimum, maximum) are
used to summarize the continuous outcome variables.Results
Morphology of fungal spores and AuNP
As shown in Figure 2, fungal spores are sphere-shaped with
spikes and a geometric diameter of 3.5 ± 0.2 μm (n = 120)
[26]. Single AuNP are spheres with a geometric diameter of
20.8 ± 3.4 nm (n = 100). AuNP in stock solution were
mostly single particles, whereas we found agglomerates of
different sizes, when AuNP were suspended in serum-free
cell culture medium.
Figure 2 Electron micrographs of micro- and nanoparticles. (A) Scanning electron micrograph of sphere-shaped fungal spores with spikes.
(B) Transmission electron micrograph of ultrathin section of epon-embedded spores. (C-F) Transmission electron micrographs of AuNP in
serum-free D-MEM: (C) single NP and small cluster of two NP, (D-F) NP clusters of various sizes. Bars: (A, B) = 3 μm; (C-F) = 200 nm.
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morphology
As shown in Table 1, the mean number of total BAL cells
obtained from OVA-allergic mice (n = 5) was significantly
higher (P = 0.001) compared to healthy controls (n = 5).
BAL cells from allergic mice consisted of 56.6 ± 3.8%
eosinophils, 25.9 ± 2.4% macrophages, 10.4 ± 0.5% neu-
trophils and 9.1 ± 1.6% lymphocytes. In sham controls,
99.6 ± 0.4% of BAL cells were macrophages. The mean
number of total BAL cells from Scnn1b-Tg animals (n = 5)
was not significantly different from WT mice (n = 5). BAL
cells from Scnn1b-Tg mice consisted of 97.8 ± 0.3%Table 1 Mean number and differential counts of BAL cells
Animals BALtotal × 10
6 % Mac
OVA-allergic 5.3* ± 0.5 25.9* ± 2.4
Sham 0.8 ± 0.3 99.6 ± 0.4
Scnn1b-Tg 0.6 ± 0.1 97.8 ± 0.3
WT 0.7 ± 0.1 99.8 ± 0.2
Mean values of n = 5 animals per group ± SEM. *Significant difference to control gro
(neutrophils); Eos, eosinophils; Lymph, lymphocytes.macrophages and 2.2 ± 0.3% lymphocytes (Table 1). In
WT animals, 99.8 ± 0.2% of the cells were macrophages.
As shown in Figure 3, BAL macrophages from OVA-
allergic and sham-sensitized mice appeared structurally
normal, although, those of OVA-allergic animals were
significantly larger (27.0 ± 1.3 μm in diameter, range
7.1 - 46.3 μm) compared to sham controls (15.8 ±
0.5 μm, range 8.2 - 25.2 μm) and any other animal
group analyzed (P < 0.001). The macrophage population of
Scnn1b-Tg mice appeared morphologically heterogeneous;
some cells were abnormally large and many had a
“foamy” cytoplasm as previously demonstrated [30,32].% PMN % Eos % Lymph
10.4* ± 0.5 56.6* ± 3.8 9.1* ± 1.6
0 0 0
0 0 2.2* ± 0.3
0 0 0
up (P < 0.05). Mac, macrophages; PMN, polymorphnuclear leukocytes
Figure 3 Size distribution and morphology of macrophages. (A) Size distribution of macrophages: Data are expressed as mean values ± SEM per
animal group; *significant difference to corresponding healthy controls (P < 0.05); #significant difference to all other animal groups (P < 0.001). (B-E) Light
micrographs of BAL cells: from (B) OVA-allergic and (C) sham-sensitized, (D) Scnn1b-Tg and (E) WT mice. Bars: 50 μm.
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also demonstrates, Scnn1b-Tg macrophages were signifi-
cantly larger (17.7 ± 0.5 μm diameter, range 5.3 - 36.2 μm)
than those of WT mice (15.9 ± 0.6 μm, range 7.5 -
26.7 μm) (P = 0.014).
Uptake and localization of particles
Electron microscopic and morphometric analysis of AuNP
uptake by BAL cells revealed that a similar percentage
of macrophages from OVA-allergic animals and sham
controls contained AuNP (61.0 ± 21.4% vs. 62.1 ± 5.7%
respectively). The percentage of BAL macrophages from
Scnn1b-Tg mice containing AuNP tended to be lower
(74.9 ± 7.2%) than in WT animals (82.0 ± 3.3%), though not
statistically significant with the number of animals included
in this study. Comparison of AuNP uptake by macrophages
obtained from healthy control groups revealed significantly
higher percentages of macrophages containing AuNP in
naïve WT, i.e. C3H/HeN:C57BL/6N mice compared to
sham-sensitized BALB/c mice (P = 0.016).
In all animal groups, AuNP were found either as single
particles in vesicles largely exceeding their size and
containing other electron dense material of mostly un-
known origin (Figure 4A), as agglomerates in vesicles of
similar size (Figure 4B) or co-localized with spores in
phagosomes (Figure 4C).
As shown in Table 2 and Figure 5, the sizes of AuNP
clusters in macrophage vesicles increased according toFigure 4 Transmission electron micrographs of internalized AuNP (arr
Single AuNP and small cluster in vesicles largely exceeding NP size and con
in vesicles slightly larger than the NP cluster. (C) AuNP co-localized with fu
an OVA-allergic mouse, in a vesicle exceeding NP size and containing othethe number of agglomerated particles, while the sizes of
the vesicles enclosing the AuNP remained constant,
irrespective of AuNP cluster size in all experimental
groups (Figure 5A). Thus, the ratio of vesicle to particle
diameter RV/P (Figure 5B) was large, i.e. ~ 20 for single
AuNP and ~ 10 for small clusters of 2 - 5 AuNP; it then
decreased to ~ 5 when clusters contained 6 - 10 AuNP
and approached RV/P ~ 1, i.e. the value representing
phagocytic particle uptake, when clusters consisted of
more than 10 AuNP. The supplementary statistical
analysis of RV/P data (Table 3) revealed no significant
difference in AuNP uptake between macrophages
from (i) the healthy and diseased animals, (ii) the two
mouse strains or (iii) the diseased animals of the two
groups. However, a significant vesicle class effect is found.
The three coefficients given in Table 3 correspond to the
effect of not being in vesicle class A (single AuNP) but in
the respective category B (2 - 5 AuNP), C (6 -10 AuNP)
or D (> 10 AuNP). All these three differences to vesicle
class A are significant and the predicted log(RV/P), thus
also the RV/P itself, decreases with increasing number of
nanoparticles.
In all groups studied, fungal spores (2.9 μm± 0.2 μm
in diameter, measured on ultrathin sections) were found
internalized as single particles. They were localized in
macrophage phagosomes of 3.4 μm± 0.1 μm diameter
(Figure 5A), with the vesicle membrane closely surround-
ing the spores (Figure 4C), resulting in a RV/P = 1.4 ± 0.1.ows) and spores in BAL cells. (A-C) AuNP in macrophages: (A)
taining substances of mostly unknown origin. (B) Large AuNP clusters
ngal spore in phagosome. (D) Small AuNP cluster in an eosinophil of
r electron dense material of unknown origin. Bars: 1 μm.
Table 2 Sizes of vesicles and internalized particles
Animals Single
NP
Vesicle RV/P Cluster Vesicle RV/P Cluster Vesicle RV/P Cluster Vesicle RV/P
1 NP 2-5 NP 2-5 NP 6-10 NP 6-10 NP > 10 NP > 10 NP
OVA-allergic 22.2 ± 1.4 466 ± 64 20.8 ± 2.5 43.4 ± 2.3 459 ± 53 11.1 ± 1.2 78.7 ± 3.3 401 ± 38 5.1 ± 0.4 156 ± 9 393 ± 25 2.7 ± 0.2
(n = 16) (n = 26) (n = 22) (n = 38)
Sham 21.0 ± 0.7 367 ± 38 17.9 ± 1.9 48.6 ± 3.3 338 ± 41 7.7 ± 1.3 83.5 ± 6.5 414 ± 34 5.2 ± 0.5 182 ± 19 393 ± 32 2.4 ± 0.2
(n = 22) (n = 28) (n = 22) (n = 30)
Scnn1b-Tg 21.5 ± 0.3 435 ± 30 20.5 ± 1.4 47.9 ± 2.5 393 ± 22 9.4 ± 0.6 74.0 ± 3.3 366 ± 25 5.3 ± 0.4 149 ± 7* 420 ± 19 3.1 ± 0.2
(n = 69) (n = 87) (n = 49) (n = 77)
WT 22.5 ± 0.4 543 ± 61 24.5 ± 2.8 50.4 ± 3.3 451 ± 43 10.3 ± 1.1 79.1 ± 3.7 404 ± 33 5.3 ± 0.5 188 ± 9 460 ± 20 2.7 ± 0.2
(n = 46) (n = 57) (n = 34) (n = 74)
Data are presented as mean values ± SEM. *Significant difference to control group (P = 0.005); n = number of measurements (vesicle and enclosed AuNP).
RV/P = ratio of vesicle to particle diameter.
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brane. Thereby, the distance of AuNP to the membrane
tended to be larger in diseased animals of both murine
models compared to the healthy mice, though not statisti-
cally significant (Figure 6A). The mean distance to the
vesicle membrane was 38.5 ± 4.1 nm in BAL cells of OVA-
allergic mice vs. 36.9 ± 3.5 nm in sham-sensitized controls
and 40.3 ± 2.7 nm in Scnn1b-Tg mice vs. 31.4 ± 2.5 nm
in WT littermates. Tomographic reconstructions (n = 3)
of single AuNP and small agglomerates, as shown in
Figure 6B, confirmed the proximity of AuNP to the
vesicle membrane. Rarely, we found AuNP that were
not enclosed by a membrane, i.e. localized in the macro-
phage cytoplasm.
In BAL cells from OVA-allergic mice, AuNP were also
found in 13.9 ± 8.3% of all observed eosinophils (n = 36),
localized in vesicles exceeding NP size and together
with other electron dense material of unknown origin
(Figure 4D). The few lymphocytes (n = 6) and neutro-
phils (n = 1) observed in OVA-allergic mice, did not
contain any AuNP.
Discussion
AuNP are of interest for medicine as inhalative drug
delivery systems for therapeutic targeting of epithelial
cells in pulmonary disease. The action of the drug,
however, may be compromised by a previous challenge
of the lungs with ambient air particles and/or a rapid
clearance of the deposited nanocarriers from the epi-
thelial surface by macrophages. The phagocytic activity
of biogenic microparticle challenged airway macrophages
with regard to AuNP uptake and lung disease is cur-
rently not known. Morphometry combined with electron
microscopy allows quantitative assessment of (nano) par-
ticle uptake by cells at the individual particle level. Using
these methods, we examined the efficiency and the mode
of particle internalization in BAL cells after sequential
ex vivo challenge with a ubiquitous biogenic micrometer-
sized particle in ambient air, i.e. fungal spores and aninhalative nanocarrier candidate, i.e. AuNP. To study
AuNP uptake in different inflammatory lung disease con-
ditions, we examined BAL cells from OVA-sensitized al-
lergic mice and Scnn1b-Tg COPD mice.
The OVA sensitization model is frequently presented
as a mouse model of asthma in the literature, although
airway inflammation in this model reflects an acute
inflammatory response, rather than the chronic inflamma-
tion observed in patients with asthma. This is a general
limitation of mouse models of experimental asthma. It
can be argued, however, that the type of inflammation
obtained in our model mimics key features of airway
disease in asthmatic patients, i.e. airway eosinophilia,
increased mucin expression and goblet cell metaplasia.
In addition, an important point addressed by our acute
asthma model in this study is the phagocytosis of nano-
particles during a lung inflammatory response. We were
able to show in a chronic asthma model, that the alveolar
macrophage population returns to baseline levels after
an 8 week cessation of allergen challenge [37]. Since the
alveolar macrophage population resumes normal levels in
the chronic model, we argue that subsequent inflamma-
tion will likely resemble the acute inflammatory response
upon successive activation.
Our results show that macrophages are inefficient at
taking up AuNP and that lung disease further hampers
this process. Macrophages from diseased lungs were
structurally altered, larger and in Scnn1b-Tg COPD mice,
fewer macrophages internalized AuNP compared to those
from healthy controls. These findings are consistent with
earlier studies on macrophage clearance of NP of similar
size but different materials [7,10,11,18]. In addition, the
finding that nanoparticles were taken up by a higher per-
centage of macrophages from naïve C3H/HeN:C57BL/6N
mice than from sham-sensitized BALB/c mice points to
a strain difference. There are clear differences in the
inflammatory response in different mouse strains. In
regard to particle uptake, different macrophage pheno-
types in the inflammatory models (Th1/Th2) are likely
Figure 5 Size distributions of vesicles and internalized particles in BAL macrophages. (A) Sizes of AuNP and vesicles containing the
particles. Data are expressed as mean values ± SEM per animal group. (B) Ratio of vesicle to particle diameter (RV/P).
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http://www.biomedcentral.com/1471-2466/14/116to be an important factor [38]. This further supports
the use of the two different models in the present study.
The asthma model used displays a Th2 phenotype, while
the adult Scnn1b-Tg mice used in this study rather
displays a Th1 phenotype.The larger size of BAL macrophages from diseased
mice compared to healthy controls is an indicator of cell
activation [39]. Macrophage activation in Scnn1b-Tg mice
was supported by other findings including a “foamy” ap-
pearance and a higher frequency of substantially enlarged
Table 3 Dependence of RV/P on health status, disease
model/mouse strain and AuNP uptake
Animal group/Vesicle class Fixed effect estimates
Value SE DF P-value
(Intercept ) 2.941 0.103 677 0.000
Healthy (Sham, WT) -0.137 0.129 13 0.307
COPD model (Scnn1b-Tg, WT) -0.044 0.118 13 0.717
Healthy, COPD model (WT) 0.172 0.162 13 0.309
Vesicle class B (2 - 5 NP) -0.817 0.056 677 0.000*
Vesicle class C (6 - 10 NP) -1.351 0.063 677 0.000*
Vesicle class D (> 10 NP) -2.004 0.055 677 0.000*
The estimates of the linear mixed effects model revealed no significant
difference between (i) the healthy and diseased animals, (ii) the disease
model, the two mouse strains or (iii) the diseased animals of the two groups
on the log of the ratio of vesicle to particle diameter, log(RV/P).
*Significant
vesicle class effect (P < 0.05), i.e. effect of not being in vesicle class A but in
the respective category B, C or D; thus RV/P decreases with increasing number
of nanoparticles. SE = standard error; DF = degrees of freedom.
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results and reported previously [30]. Moreover, in a recent
study it was demonstrated that morphological activation
of macrophages in Scnn1b-Tg mice is associated with
upregulation of macrophage elastase (MMP12) and other
signature genes of alternative macrophage activation
(Alox15, Arg1, Chi3l3, Chi3l4, Mgl2, Mmp12, Retnla) [32].
Macrophages from OVA-allergic mice were even larger
than those of Scnn1b-Tg mice. This is in accordance with
the inflammation status of the two models, i.e. acute
inflammation in the allergic asthmatic and chronic
inflammation in COPD mice. By virtue of these findings,
one might expect a disease-related increase in phagocytic
macrophages. Oppositely, antigen sensitization has been
reported to decrease the phagocytic activity of macro-
phages in experimental asthma in rats [15]. However, both
are not the case for AuNP uptake, because the percentage
of AuNP-containing macrophages was similar in OVA-
allergic mice and sham controls. Less macrophages from
Scnn1b-Tg mice contained AuNP compared to those
from WT mice. This points to a phenotype change in
the macrophage population to a less phagocytic type.
This finding is consistent with our recent study on lung-
cell distribution of inhaled AuNP, where we found less
efficient and delayed NP uptake by surface macrophages
in Scnn1b-Tg mice [18]. Decreased uptake of AuNP by
macrophages results in their prolonged residence time
on the epithelial surface. This facilitates the interaction
of AuNP with the epithelial cells or their translocation
into tissues beyond. This finding is of interest for thera-
peutic targeting of epithelial cells in COPD/emphysema
using nanocarriers as drug delivery systems. In the
case of inhaled harmful NP, this may be an important
factor in disease initiation and/or perpetuation including
exacerbations.The intracellular localization of particles within vesicles
demonstrates endocytic uptake. Macrophages phagocytosed
fungal spores, as expected and consistent with previous
findings [26]. Phagocytosis is reflected by the tight enclos-
ure of the microparticle by the vesicle membrane [9]. In
our study, vesicles and particles were approximately the
same size; hence, the RV/P value was close to 1. Small RV/P
values representing particle phagocytosis were also obtained
for AuNP clusters consisting of > 10 NP (> 200 nm in
diameter). In contrast, single AuNP (20 nm in diameter)
were contained in vesicles largely exceeding particle
size (RV/P values ~ 20). Such vesicles contained additional
other material and were identified as phagosomes, when
they contained spores. Thus, it is likely that single AuNP
attach to the cell membrane, which is then used by the
macrophages to phagocytose larger-sized foreign mater-
ial, including fungal spores. This “unintentional” uptake
of NP correlates with data from previous inhalation
studies in rodents using TiO2 and Au nanoparticles of
approximately 20 nm diameter [11,18]. In the latter
study, fast attachment of AuNP to lung cells has been
demonstrated [18].
Internalization of AuNP that are attached to the mem-
brane is further supported by the localization of internal-
ized single AuNP and small clusters near and in fairly
constant distance to the vesicle membrane. This close
particle-membrane association has also been observed
in the studies discussed above [11,18]. The distance of
30 – 40 nm between particle and vesicle membrane
may indicate binding of AuNP to membrane receptors.
This can be visualized in TEM as electron dense material
between the particle and the cell membrane. To reach
highest possible receptor density in our specimens, we
analyzed small AuNP clusters in vesicles and used high
resolution electron tomography. However, we did not
find any electron dense material between particles and
vesicle membrane. Adhesion forces may represent an
alternative mechanism for the close localization of AuNP
to the vesicle membrane [40].
The following mechanisms are not considered as major
pathways of AuNP uptake by airway macrophages. Pino-
cytosis, because the AuNP-containing vesicles are 4 times
larger than what is reported for such endosomes [41,42].
Non-endocytic, passive uptake of particles, found for poly-
styrene particles of ≤ 200 nm diameter in red blood cells
and cytochalasin D treated macrophages [43], because we
found AuNP almost exclusively in vesicles. Primary vesicu-
lar localization of AuNP in lung cells, i.e. uptake by endo-
cytic mechanisms is in-line with our recent study on lung-
cell distribution of inhaled 20-nm AuNP in Scnn1b-Tg and
WT mice [18] and with reports from others [44-46].
Our comprehensive statistical analysis of RV/P values
in BAL macrophages confirmed for the first time the
change in the uptake mechanism determined by particle
Figure 6 (See legend on next page.)
Geiser et al. BMC Pulmonary Medicine 2014, 14:116 Page 11 of 13
http://www.biomedcentral.com/1471-2466/14/116
(See figure on previous page.)
Figure 6 AuNP localization with respect to the vesicle membrane. (A) Distance of AuNP to the vesicle membrane as measured on ultrathin
sections of BAL macrophages (n = number of measurements). Data are expressed as mean values ± SEM per animal group. (B) Electron tomogram
of small AuNP clusters in macrophage vesicle. Upper left: topmost, middle and lowest image of the 3D stack (bar: 100 nm) and magnified AuNP in
different z-heights of the stack (1 - 3, bar: 50 nm). Upper right: middle image from the stack indicating connections between two vesicles (arrowheads)
and showing AuNP (fat arrows) in close contact to vesicle membrane (arrows). Lower left: Bottom image of the tomogram stack (xy-plane) shows the
sectioning xz-plane with automatic reconstruction of AuNP (yellow) and manual segmentation of vesicles (green). Lower right: reconstruction without
the original electron micrograph. Arrowheads point to the space between NP and vesicle membrane. Bars of lower images: 100 nm.
Geiser et al. BMC Pulmonary Medicine 2014, 14:116 Page 12 of 13
http://www.biomedcentral.com/1471-2466/14/116size. It could not be shown that AuNP uptake by BAL
macrophages depends either on the health status of the
animals or on the disease model/mouse strain.
Finally, in OVA-allergic mice, we found eosinophils con-
taining AuNP, emphasizing the emerging notion that this
cell type may internalize foreign material. Eosinophil uptake
of foreign objects has been previously documented with
bacteria [47] and antigen-antibody complexes [48]. Uptake
of 20-nm AuNP was also demonstrated in peritoneal eosin-
ophils of rats, with NP localized in vesicles of < 100 nm in
diameter [49]. Hence, in allergic airway disease, eosinophils
may substantially contribute to the clearance of NP from
the lung surface. Under these circumstances epithelial tar-
geting with AuNP as nanocarriers for drug delivery may be-
come inefficient, because a substantial amount of NP may
be engulfed by additional immune cells present on the air-
way surface in lung disease and may not reach target cells.
Conclusions
In summary, our study examined macrophage uptake of
AuNP in fungal-spore challenged BAL cells obtained from
murine models of allergic asthma and COPD. Macro-
phages of diseased animals were significantly larger than
those of the corresponding controls, indicating a state of
activation. Scnn1b-Tg mice had a lower percentage of
AuNP containing macrophages, pointing to a change in
macrophage phenotype to a less phagocytic population.
The resulting prolonged residence time of AuNP on lung
surfaces may be favorable for therapeutic targeting of the
lung parenchyma by inhaled aerosols. The localization of
single AuNP or small particle clusters in large vesicles and
close to the membrane, irrespective of the animal model
and health status, shows co-uptake of AuNP by macro-
phages during phagocytic clearance of micrometer-sized
particulate deposits from the lung surfaces. The finding
that eosinophils in asthmatic lungs significantly internalize
AuNP is important for the application of nanocarriers as
drug delivery systems for inhalation therapy. The findings
of the present study contribute to our understanding of
NP uptake by airway macrophages under healthy condi-
tions and in models of the two most relevant inflamma-
tory lung diseases COPD and asthma, and provide a basis
for further investigation into the application of medicinal
nanoaerosols as well as unraveling the mechanisms
responsible for adverse health effects of inhaled NP.Abbreviations
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